IBBQ ETF holdings (NASDAQ) | MetaTrader

Открыть полный график

Обзор Все активы Тепловая карта

Ключевые активы Market Value Shares Weight %

Invesco Private Prime Fund 10.83 M 10.83 M 14.29%

GILD Gilead Sciences, Inc. 7.28 M 48.86 K 9.61%

VRTX Vertex Pharmaceuticals Inc. 7.04 M 14.18 K 9.30%

AMGN Amgen Inc. 6.91 M 17.80 K 9.12%

REGN Regeneron Pharmaceuticals, Inc. 4.56 M 5 839.00 6.03%

Invesco Private Government Fund 4.20 M 4.20 M 5.55%

ALNY Alnylam Pharmaceuticals, Inc. 2.49 M 7 470.00 3.28%

INSM Insmed Inc. 1.80 M 12.06 K 2.38%

BIIB Biogen Inc. 1.59 M 8 295.00 2.10%

ARGX argenx SE 1.26 M 1 648.00 1.67%

UTHR United Therapeutics Corp. 1.23 M 2 437.00 1.62%

MRNA Moderna, Inc. 1.18 M 22.11 K 1.56%

ILMN Illumina, Inc. 1.16 M 8 646.00 1.53%

ROIV Roivant Sciences Ltd. 1.14 M 39.37 K 1.50%

INCY Incyte Corp. 1.13 M 11.11 K 1.49%

RPRX Royalty Pharma PLC 1.12 M 24.17 K 1.47%

RVMD Revolution Medicines, Inc. 1.12 M 10.94 K 1.47%

VTRS Viatris Inc. 973.11 K 65.18 K 1.28%

Ascendis Pharma A/S 811.18 K 3 474.00 1.07%

NBIX Neurocrine Biosciences, Inc. 746.02 K 5 641.00 0.98%

1
2
3
4
5
6
7
8
...
14

Новости

Health Care Flies High

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies